What does Nsthesiology do?

Nsthesiology is a specialist medical practice in Stoumont. Private Limited, started on 30 January 2020, 1 establishment.

What is the address of Nsthesiology?

The registered office of Nsthesiology is located at Targnon 60, 4987 Stoumont.

Is Nsthesiology still active?

Yes. According to the CBE (31 October 2026) Nsthesiology is active, legal situation “Normale toestand”, started on 30 January 2020.

Is Nsthesiology registered on Peppol?

Yes, Nsthesiology is registered on the Peppol network with ID 0208:0742725238.

What is the enterprise number of Nsthesiology?

The enterprise number of Nsthesiology is BE0742725238.

When was Nsthesiology founded?

Nsthesiology was founded on 30 January 2020.

Who are the directors of Nsthesiology?

According to the 2025 annual accounts, the directors of Nsthesiology are: Nicolas Smal.

Is Nsthesiology a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 January 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Nsthesiology make in 2025?

Nsthesiology posted a profit after taxes of € 123,824 in financial year 2025.

What is the revenue of Nsthesiology?

As a small company, Nsthesiology is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 319,380.

Nsthesiology (Private Limited) - Stoumont - BE0742725238

Dossier Nsthesiology, printed on 1 November 2026 from databakkes.be/en/0742725238/nsthesiology. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Nsthesiology from Stoumont, company number BE0742725238, closed financial year 2025 with a result of € 123,824 after tax. For that financial year Nsthesiology recorded a gross margin of € 319,380 and equity of € 310,991. Compared with financial year 2024, the result moved from € 170,160 to € 123,824. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 310,991

▲ 66% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 123,824

▼ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 237,212

▲ € 203,120 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 306,991.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 54,388

▼ 44% vs 2024

€ 43,482 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 4,448

▼ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 30,333

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 133,145 Gross margin 2022: € 133,145 First fiscal year in the series	€ 242,409 Gross margin 2023: € 242,409 ▲ 82% vs 2022 (€ 133,145) Favourable step	€ 290,384 Gross margin 2024: € 290,384 ▲ 20% vs 2023 (€ 242,409) Favourable step	€ 319,380 Gross margin 2025: € 319,380 ▲ 10% vs 2024 (€ 290,384) Favourable step	▲ 10%
Profit after taxes	€ 35,395 Profit after taxes 2022: € 35,395 First fiscal year in the series	€ 115,686 Profit after taxes 2023: € 115,686 ▲ 227% vs 2022 (€ 35,395) Favourable step	€ 170,160 Profit after taxes 2024: € 170,160 ▲ 47% vs 2023 (€ 115,686) Favourable step	€ 123,824 Profit after taxes 2025: € 123,824 ▼ 27% vs 2024 (€ 170,160) Unfavourable step	▼ 27%
Equity	€ 281,322 Equity 2022: € 281,322 First fiscal year in the series	€ 57,008 Equity 2023: € 57,008 ▼ 80% vs 2022 (€ 281,322) Unfavourable step	€ 187,168 Equity 2024: € 187,168 ▲ 228% vs 2023 (€ 57,008) Favourable step	€ 310,991 Equity 2025: € 310,991 ▲ 66% vs 2024 (€ 187,168) Favourable step	▲ 66%
Total debts	€ 212,774 Total debts 2022: € 212,774 First fiscal year in the series	€ 281,128 Total debts 2023: € 281,128 ▲ 32% vs 2022 (€ 212,774) Unfavourable step	€ 102,796 Total debts 2024: € 102,796 ▼ 63% vs 2023 (€ 281,128) Favourable step	€ 146,841 Total debts 2025: € 146,841 ▲ 43% vs 2024 (€ 102,796) Unfavourable step	▲ 43%
Cash	€ 71,069 Cash 2022: € 71,069 First fiscal year in the series	€ 34,487 Cash 2023: € 34,487 ▼ 51% vs 2022 (€ 71,069) Unfavourable step	€ 34,092 Cash 2024: € 34,092 ▼ 1% vs 2023 (€ 34,487) Unfavourable step	€ 237,212 Cash 2025: € 237,212 ▲ € 203,120 vs 2024 (€ 34,092) Favourable step	▲ € 203,120
Retained profit	€ 277,322 Retained profit 2022: € 277,322 First fiscal year in the series	€ 53,008 Retained profit 2023: € 53,008 ▼ 81% vs 2022 (€ 277,322) Unfavourable step	€ 183,168 Retained profit 2024: € 183,168 ▲ 246% vs 2023 (€ 53,008) Favourable step	€ 306,991 Retained profit 2025: € 306,991 ▲ 68% vs 2024 (€ 183,168) Favourable step	▲ 68%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 340,000 Dividend 2023: € 340,000 Unchanged (€ 0) Unchanged	€ 40,000 Dividend 2024: € 40,000 ▼ 88% vs 2023 (€ 340,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 40,000) Unchanged	▼ 100%
Bank debt	€ 183,464 Bank debt 2022: € 183,464 First fiscal year in the series	€ 140,664 Bank debt 2023: € 140,664 ▼ 23% vs 2022 (€ 183,464) Favourable step	€ 97,641 Bank debt 2024: € 97,641 ▼ 31% vs 2023 (€ 140,664) Favourable step	€ 54,388 Bank debt 2025: € 54,388 ▼ 44% vs 2024 (€ 97,641) Favourable step	▼ 44%
Balance sheet total	€ 494,096 Balance sheet total 2022: € 494,096 First fiscal year in the series	€ 338,136 Balance sheet total 2023: € 338,136 ▼ 32% vs 2022 (€ 494,096) Unchanged	€ 289,964 Balance sheet total 2024: € 289,964 ▼ 14% vs 2023 (€ 338,136) Unchanged	€ 457,832 Balance sheet total 2025: € 457,832 ▲ 58% vs 2024 (€ 289,964) Unchanged	▲ 58%

Key figures of Nsthesiology, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Nsthesiology?

What happened at Nsthesiology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 123,824 (▼ 27% vs 2024). filed late Source: NBB ↗
Jan 30, 2020 New establishment in Stoumont. KBO
Jan 30, 2020 Start of the company according to the CBE. KBO

In short

From € 35,395 profit in 2022 to € 123,824 profit in 2025.

Paid € 99,519 in corporate taxes since 2022.

Best year ever: 2024, with € 170,160 profit.

Paid out € 380,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nicolas Smal

Nsthesiology

Behind Nsthesiology is Nicolas Smal.

Directors

According to the 2025 annual accounts

Nicolas Smal

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Targnon 60

4987 Stoumont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0742.725.238

VAT number

BE 0742.725.238

Registered office

Targnon 60, 4987 Stoumont

Names & denominations

Nsthesiology

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 January 2020

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van medisch specialisten

Fokken en houden van schapen en geiten

View on CBE Public ↗ Annual accounts (NBB) ↗

Nsthesiology

Financials

What happened to Nsthesiology?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions